Pharmafile Logo
Pharmafocus logo
Advanced Search

HSDD

Showing 3 posts of 3 posts found.

16792957331_d9572dbdf4_z

FDA approve libido enhancing drug for women with low sexual desire

June 24, 2019
Sales and Marketing FDA, HSDD, health, pharma, viagra, vyleesi

The FDA has approved a new drug for women with low libido.The FDA has approved AMAG Pharmaceuticals’ bremelanotide – sold …

News
Sprout sign

‘Female Viagra’ goes on sale in the US

October 20, 2015
Addyi, HSDD, Sprout, female viagra, flibanserin, hypoactive sexual desire disorder

The pill dubbed the female version of Viagra – Sprout Pharmaceuticals’ Addyi – has gone on sale in the US. …

News
Sprout sign

FDA approves ‘female viagra’

August 19, 2015
Research and Development, Sales and Marketing Addyi, FDA, HSDD, Sprout, Sprout Pharmaceuticals, flibanserin, hypoactive sexual desire disorder

The FDA has approved Sprout Pharmaceuticals’ Addyi, a controversial libido-enhancing drug for women that has been dubbed the ‘female viagra’. …

News

Latest content

Beckman Coulter Life Sciences and Watchmaker Genomics enter collaboration

May 1, 2024

Veru announces first patients enrolled in phase 2b trial for weight loss treatment

May 1, 2024

Bayer and Evotec to collaborate on precision cardiology

April 30, 2024

PeptiDream and Novartis extend peptide discovery collaboration

April 30, 2024

Pfizer’s Beqvez approved by FDA for haemophilia B treatment

April 29, 2024